The NMPA, or National Medical Products Administration, is the regulatory authority in China responsible for overseeing the safety and efficacy of medical products, including drugs, medical devices, and cosmetics. Established in 2018, it aims to ensure that these products meet strict quality standards before they can be marketed to the public. The NMPA plays a crucial role in protecting public health by conducting evaluations, inspections, and post-market surveillance. It also collaborates with international regulatory bodies to harmonize standards and improve the overall safety of medical products available in the market.